Related Experiment Video

Updated: May 14, 2026

Evaluation of Synapse Density in Hippocampal Rodent Brain Slices
07:44

Evaluation of Synapse Density in Hippocampal Rodent Brain Slices

Published on: October 6, 2017

Malignant synaptic growth and Alzheimer's disease

Ehren L Newman1, Christopher F Shay, Michael E Hasselmo

  • 1Center for Memory & Brain, Boston University, 2 Cummington St, Boston, MA 02215, USA.

Future Neurology
|February 20, 2013
PubMed

Insights

The malignant synaptic growth hypothesis offers a viable explanation for Alzheimer's disease progression. This review updates the model with recent evidence and discusses its relation to other Alzheimer's disease hypotheses.

Area of Science:

  • Neuroscience
  • Pathophysiology
  • Molecular Biology

Background:

  • Alzheimer's disease is a progressive neurodegenerative disorder.
  • Existing models include the cholinergic hypothesis and the amyloid cascade hypothesis.
  • The malignant synaptic growth hypothesis, proposed in 1994, offers an alternative perspective.

Purpose of the Study:

  • To refresh and update the malignant synaptic growth hypothesis with recent empirical support.
  • To compare and contrast the malignant synaptic growth hypothesis with other leading Alzheimer's disease models.
  • To propose falsifiable predictions and potential therapeutic avenues based on this hypothesis.

Main Methods:

  • Literature review and synthesis of empirical data.
  • Comparative analysis of different Alzheimer's disease hypotheses.
  • Theoretical modeling and prediction generation.

Main Results:

  • The malignant synaptic growth hypothesis remains a viable model for Alzheimer's disease.
  • Updated evidence supports the hypothesis's mechanisms of synaptic dysfunction.
  • Points of alignment and contention with other models were identified.

Conclusions:

  • The malignant synaptic growth hypothesis provides a unique framework for understanding Alzheimer's disease.
  • Further research and falsifiable predictions can refine therapeutic strategies.
  • Targeting synaptic growth mechanisms may offer novel treatment avenues for Alzheimer's disease.
Keywords:
Alzheimer’sacetylcholinecomputational modeldementiaexcitotoxicitylong-term potentiationneurofibrillary tanglesplasticitytauβ amyloid

More Related Videos

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons06:23

Visualizing Axonal Growth Cone Collapse and Early Amyloid β Effects in Cultured Mouse Neurons

Published on: October 30, 2018

A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes06:43

A Novel In Vitro Live-imaging Assay of Astrocyte-mediated Phagocytosis Using pH Indicator-conjugated Synaptosomes

Published on: February 5, 2018

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Long-term Depression01:03

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...
Long-term Depression01:05

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...